Chuankun Li
Overview
Explore the profile of Chuankun Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tao R, Li D, Shi H, Pang S, Lin Y, Li C
Sci Rep
. 2025 Mar;
15(1):8173.
PMID: 40059208
As petrochemical industry enterprises expand their scale and production capacity, equipment and storage facilities are increasingly automated. But its production safety issues are gradually exposed, including fires, poisonings, and explosions...
2.
Duan J, Long G, Xu X, Liu W, Li C, Chen L, et al.
Micromachines (Basel)
. 2024 Nov;
15(11).
PMID: 39597116
In this paper, hierarchical micro/nano structures composed of periodic microstructures, laser-induced periodic surface structures (LIPSS), and nanoparticles were fabricated by femtosecond laser processing (LP). A layer of hydrophobic species was...
3.
Mu B, Jing J, Li R, Li C
J Bioenerg Biomembr
. 2024 Sep;
56(5):495-504.
PMID: 39235700
Previous studies have suggested that N6-methyladenosine (mA) modification of RNA affects fundamental aspects of RNA metabolism, and mA dysregulation is implicated in various human diseases, including Alzheimer's disease (AD). This...
4.
Li C, Li R, Bai X, Jiang H
Gen Physiol Biophys
. 2024 Aug;
43(5):423-434.
PMID: 39140685
This study was designed to dissect the function of plasmacytoma variant translocation 1 (PVT1) in hippocampal neuron injury in epilepsy and its possible molecular basis. Status epilepticus (SE) mouse model...
5.
Mu B, Jing J, Li R, Li C
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Jul;
398(1):855-865.
PMID: 39073416
Glioblastoma (GBM) is the most aggressive form of brain cancer, characterized by rapid growth and invasion into surrounding brain tissue. Ubiquitin-specific protease 9X (USP9X) has emerged as a key regulator...
6.
Li C, Li R, Wang Y, Jiang H
Drug Dev Res
. 2024 Jul;
85(5):e22230.
PMID: 38967729
The CDK4/CDK6 inhibitor palbociclib has shown the encouraging promise in the treatment of glioma. Here, we elucidated how palbociclib exerts suppressive functions in the M2 polarization of glioma-related microglia and...
7.
Li C, Jing J, Wang Y, Jiang H
Pathol Res Pract
. 2024 Jul;
260:155438.
PMID: 38964117
The function of glioma stem cells (GSCs) is closely related to the progression of glioblastoma multiforme (GBM). Centromere protein A (CENPA) has been confirmed to be related to the poor...
8.
Li Q, Zhou L, Wang M, Wang N, Li C, Wang J, et al.
Biomed Pharmacother
. 2024 Mar;
173:116383.
PMID: 38453578
No abstract available.
9.
Li C, Yang J, Lei S, Wang W
Brain Res
. 2021 Apr;
1765:147500.
PMID: 33895155
Spindle and kinetochore-related complex subunit 3 (SKA3) is a key modulator of the progression of multiple tumor types. However, the involvement of SKA3 in glioblastoma (GBM) has not been well...
10.
Li C, Yang J, Wang W, Li R
J Bioenerg Biomembr
. 2021 Jan;
53(1):61-71.
PMID: 33394310
Phospholysine phosphohistidine inorganic pyrophosphate phosphatase (LHPP) has been recently identified as a novel inhibitor of multiple tumors; however, its role in glioblastoma (GBM) has not been investigated. This study aimed...